
Athenian Venture Partners
Description
Athenian Venture Partners, established in 1997 and headquartered in Fort Lauderdale, Florida, was a venture capital firm with a specialized focus on early-stage investments within the information technology and healthcare sectors. The firm aimed to identify and support promising startups poised for significant growth in these critical industries. Their investment thesis centered on leveraging technological advancements to disrupt traditional markets and improve healthcare outcomes.
Over its active period, Athenian Venture Partners successfully raised several funds, demonstrating its commitment to the venture ecosystem. Notable among these were Athenian Venture Partners II, which closed with $50 million in 1997, followed by Athenian Venture Partners III, securing $100 million in 1999. Their largest fund, Athenian Venture Partners IV, raised $150 million in 2000. Collectively, these funds provided the capital base for their investment activities, supporting a diverse portfolio of companies.
The firm's portfolio included companies like Acusphere, which successfully completed an IPO, and Health Dialog, later acquired by BUPA, showcasing their ability to back ventures with successful exit potential. However, public records and industry databases indicate that Athenian Venture Partners ceased making new investments around the mid-2000s, with their last reported activities dating back to approximately 2006-2008.
Consequently, while Athenian Venture Partners played a role in the early 21st-century venture landscape, it is no longer an active investor in new companies. Due to this prolonged period of inactivity in new deal sourcing, it is not possible to reliably determine or provide current typical first check sizes for this entity. The firm's historical investment parameters would not be relevant for assessing its current or future investment capacity.
Investor Profile
Athenian Venture Partners has backed more than 23 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 30% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Software.
Stage Focus
- Series Unknown (39%)
- Series C (22%)
- Series B (17%)
- Series A (13%)
- Series D (9%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Therapeutics
- Internet
- Private Social Networking
- Information Services
- Online Portals
- Seo
- Intelligent Systems
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.